Showcases
Pricing
Log In
Free Trial
US-listed companies
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
LYEL
Market cap
$368.44M
P/E ratio
Add to your list
Add to your list
Back to summarized table
B
M
K
USD
iso4217:USD
Annual
Quarterly
Download CSV
Income statement
Balance sheet
Cash flow
Dec 31,
2023
Revenues
0
Research and development
183
General and administrative
67
Other operating income, net
3
Total operating expenses
247
Loss from operations
-247
Interest income, net
23
Other income (expense), net
2
Impairment of other investments
13
Total other income (loss), net
12
Net loss
-235
Net unrealized gain (loss) on marketable securities
8
Comprehensive loss
-227
Net loss
-235
Earnings Per Share, Basic
-0.93
Earnings Per Share, Basic
-0.93
Earnings Per Share, Diluted
-0.93
Earnings Per Share, Diluted
-0.93